New MRI-radiation hybrid machine in Alberta expected to improve cancer treatment by at least 20 per cent
Technology in Alberta that is expected to allow doctors to more accurately and effectively treat cancerous tumours with radiation enters clinical trials next week.
This next step, after 15 years of work, was celebrated in Edmonton on Friday as a "game changer" and "true medical breakthrough."
The LMR, or Linac-MR machine, simultaneously delivers radiotherapy and high-resolution imaging – something researchers say was previously considered impossible because the magnetic field and x-rays of the two machines interfere with each other if placed within 10 metres.
But a tumour's position can shift with a patient's movement, as they go between machines, or even by breathing. So doctors need to use radiation more conservatively to avoid hitting healthy tissue or organs near a tumour, which in turn means lower radiation doses and a higher number of treatment sessions.
"Say I know exactly where the tumour is without killing healthy tissue: We can calculate the cure rates will improve by 20 to 40 per cent for all solid tumours," creator Dr. Gino Fallone told reporters.
The medical physicist at the University of Alberta has been working on the idea with researchers from Edmonton's Cross Cancer Institute and Alberta Health Services since 2008.
Dr. Nawaid Usmani, who will lead the clinical study, also expects the machine will be able to treat tumours that are difficult to access – like prostate, liver, and pancreatic cancers.
"Over the course of your career, it's very rare to be involved in a true innovation, something that revolutionalizes how treatment is administered and is able to offer new treatments to patients," he commented during the news conference at the Cross Cancer Institute.
"I'm very fortunate to have been involved in this innovation as I've been able to witness right before my eyes this concept become a reality."
'VERY OPTIMISTIC'
Usmani's team is hoping to include 100 patients in the LMR's first year-long trial. Five more phases, each with roughly 100 more participants, will follow.
Marvin Bahry, an 84-year-old prostate cancer patient, will be the first-ever clinical trial participant.
Bahry first had prostate cancer around 12 years ago and told CTV News he has "high hopes" to beat it again.
"I'm very optimistic that all of his research and the hard work of Dr. Usmani and other doctors and nurses and so on, will benefit not only me but all the other people who come here," he said.
"Any good that comes out of it from me will benefit others and that's my little contribution to others in this world…I see nothing but good coming out of all of this."
Jordan Turko, a Cross Cancer Institute fundraiser and cancer survivor, echoed Bahry's thoughts: "When I think about innovations like this, it buys folks like me more time."
In April 2022, at 30 years old, he was diagnosed with Stage 4 lung cancer his doctor believes developed over a period of just four months. Nine months of targeted radiation and pill therapy later, he says his cancer has "fully retreated."
"For the average person, as time goes on, you get less of it. It goes on, you get a little older. But for cancer patients, it's ironic that within innovations like this, when we get a little more time," Turko said of the LMR.
"So things like this are a really big deal because they buy a little more time. Which hopefully means that another great innovator will buy more time and give us more moments in our life."
With files from CTV News Edmonton's Amanda Anderson
CTVNews.ca Top Stories
BREAKING Ontario Premier Doug Ford threatens to cut off energy to U.S. in response to Trump's tariffs
Ontario Premier Doug Ford threatened to cut off energy supply to the U.S. in response to the tariffs President-elect Donald Trump plans to impose on all Canadian imports.
Elon Musk calls Justin Trudeau 'insufferable tool' in new social media post
Billionaire Elon Musk is calling Prime Minister Justin Trudeau 'an insufferable tool' in a new social media post on Wednesday. 'Won't be in power for much longer,' Musk also wrote about the prime minister on 'X.'
Trudeau will have to 'kiss the ring' to achieve smoother bilateral relations with Trump: John Bolton
If Prime Minister Justin Trudeau wants to get on U.S. president-elect Donald Trump's good side for the sake of a smooth bilateral relationship, he'll likely have to be openly deferential, says former U.S. National Security Advisor, John Bolton.
Banks lower prime rates following Bank of Canada move
Canadian financial institutions are lowering their prime lending rates to match the decrease announced by the Bank of Canada.
Police locate labyrinth of tunnels connecting tents to generator in Hamilton encampment
Hamilton police say that they discovered a series of 'man-made holes and tunnels' during a patrol of a downtown encampment earlier this week.
Luxury real estate brokers charged in federal indictment with sex trafficking in NYC
Two luxury real estate brokers and their brother have been charged with luring, drugging and violently raping dozens of women over more than a decade.
Certain foods may disrupt your body's fight against cancer cells, study says
The food you eat may be affecting your body’s ability to fight cancer cells in the colon, according to a new study.
What happens next with Alex Jones' Infowars? No certainty yet after sale to The Onion is rejected
The Onion's rejected purchase of Infowars in an auction bid supported by families of the Sandy Hook Elementary shooting dealt them a new setback Wednesday and clouded the future of Alex Jones' conspiracy theory platform, which is now poised to remain in his control for at least the near future.
Canada Post strike: Talks deadlocked as sides clash on wages
Negotiations between Canada Post and the union representing its workers appear to be in a deadlock as the two sides remain far apart on wages and other issues.